Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

Background The inflammatory biomarker YKL‐40 has previously been studied as a potential risk marker in cardiovascular disease. We aimed to assess the prognostic reclassification potential of serum YKL‐40 in patients with stable coronary artery disease. Methods and Results The main study population w...

Full description

Bibliographic Details
Main Authors: Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud, Jens Kastrup
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
CHI3L1
cohort study
coronary atherosclerosis
YKL‐40
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014634

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.014634

Similar Items